The ROE as of November 2025 (TTM) for Revance Therapeutics, Inc. (RVNC) is 49.59%

According to Revance Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is 49.59%. This represents a change of 40.64% compared to the average of 35.26% of the last 4 quarters.

Revance Therapeutics, Inc. (RVNC) Historical ROE (quarterly & annually)

How has RVNC ROE performed in the past?

The mean historical ROE of Revance Therapeutics, Inc. over the last ten years is -343.64%. The current 49.59% ROE has changed -114.43% with respect to the historical average. Over the past ten years (40 quarters), RVNC's ROE was at its highest in in the June 2022 quarter at 2.34%. The ROE was at its lowest in in the December 2022 quarter at -1147.24%.

Revance Therapeutics, Inc. (RVNC) ROE by Quarter and Year

Discovering the peaks and valleys of Revance Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Revance Therapeutics, Inc. (RVNC) Average ROE

How has RVNC ROE performed in the past?

The current ROE of Revance Therapeutics, Inc. (RVNC) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Revance Therapeutics, Inc. (RVNC) ROE vs. Peers

How is RVNC’s ROE compared to its peers?

Revance Therapeutics, Inc.’s ROE is greater than Orchard Therapeutics plc (-5.12%), greater than G1 Therapeutics, Inc. (-92.13%), greater than Vigil Neuroscience, Inc. (-138.30%), less than Checkpoint Therapeutics, Inc. (916.24%), greater than Y-mAbs Therapeutics, Inc. (-24.60%), greater than Climb Bio, Inc. (-23.10%), greater than iTeos Therapeutics, Inc. (-35.52%), less than Claritev Corporation (3.19%), less than Big Cypress Acquisition Corp. (53.70%), greater than SomaLogic, Inc. (-18.59%),

Build a custom stock screener for Revance Therapeutics, Inc. (RVNC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Revance Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Revance Therapeutics, Inc. (RVNC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Revance Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.